Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 3

Results: 36

Evaluation of potential drug-drug interactions in cancer patients at a tertiary care hospital in Pakistan.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 618, doi. 10.1177/10781552221074629

By:

Choudary, Nida Ashraf;
Khan, Asad;
Wahid, Abdul;
Abubakar, Muhammad;
Atif, Muhammad;
Ahmad, Nafees

Publication type:

Article

Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 551, doi. 10.1177/1078155221998738

By:

Santos, Amanda C;
Land, Marcelo G P;
Lima, Elisangela C

Publication type:

Article

Evaluating Clostridioides difficile infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibiotics.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 542, doi. 10.1177/1078155221998735

By:

Keats, Kelli R;
Stitt, Tia M;
Chastain, Daniel B;
Jivan, Bhaumik P;
Matznick, Elizabeth;
Waller, Jennifer L;
Clemmons, Amber B

Publication type:

Article

Assessing the impact of chemotherapy-induced nausea and vomiting on patients' quality of life: An Arabic version of the Functional Living Index-Emesis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 535, doi. 10.1177/1078155221998447

By:

Alhammad, Abdullah M;
Alkhudair, Nora;
Alzaidi, Rawan;
Almosabhi, Latifa S;
Aljawadi, Mohammad H

Publication type:

Article

Patient-reported outcomes and digital literacy of patients treated in an oncology day hospital unit.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 530, doi. 10.1177/1078155221996041

By:

del Rosario García, Betel;
Morales Barrios, José Alberto;
Viña Romero, María M;
Ramos Díaz, Ruth;
Nazco Casariego, Gloria J;
Jiménez Sosa, Alejandro;
Oramas Rodríguez, Juana M;
Gutiérrez Nicolás, Fernando

Publication type:

Article

Safety and efficacy of bone-modifying agents among multiple myeloma patients: A retrospective cohort study.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 523, doi. 10.1177/1078155221996039

By:

Billias, Christina;
Langer, Megan;
Ursu, Sorana;
Schorr, Rebecca

Publication type:

Article

Implementation, utilization, and evaluation of a pharmacist-driven romiplostim dosing service for patients with immune thrombocytopenia at a multisite cancer centre.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 613, doi. 10.1177/10781552211073763

By:

Moore, Donald C.;
Elmes, Joseph B.;
Gebru, Tsion;
Lavery, Lesli A.;
Pellegrino, Annie;
Plesca, Dragos

Publication type:

Article

Cancer procoagulant inhibitors: New drugs for an old target.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 695, doi. 10.1177/10781552211073606

By:

Tafazoli, Ali

Publication type:

Article

Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 686, doi. 10.1177/10781552211073575

By:

Davis, James A.;
Shockley, Abigail;
Glode, Ashley E.

Publication type:

Article

Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 664, doi. 10.1177/10781552211073470

By:

Franco, Julia;
de Souza, Rafael N;
Lima, Tácio de M;
Moriel, Patricia;
Visacri, Marília B

Publication type:

Article

Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 691, doi. 10.1177/10781552211073468

By:

Giuliani, Jacopo

Publication type:

Article

Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 635, doi. 10.1177/10781552211073139

By:

Tanriverdi, Ozgur;
Yildiz, Aysegul

Publication type:

Article

Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 646, doi. 10.1177/10781552211072468

By:

Dela-Pena, Jacqueline C.;
King, Madeleine A.;
Brown, Julia;
Nachar, Victoria R.

Publication type:

Article

Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 627, doi. 10.1177/10781552211072467

By:

Wyatt, Houston;
Zuckerman, Autumn D.;
Hughes, Mitchell E.;
Arnall, Justin;
Miller, Ryan

Publication type:

Article

Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 763, doi. 10.1177/10781552211072465

By:

Aslaner Ak, Muzeyyen;
Ertop Doğan, Pelin;
Sahip, Birsen

Publication type:

Article

Nivolumab induced hypophysitis in an advanced RCC patient.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 759, doi. 10.1177/10781552211072212

By:

Korkmaz Yilmaz, Merve;
Gulturk, Ilkay;
Tacar, Seher Yildiz;
Yilmaz, Mesut

Publication type:

Article

Carfilzomib-induced thrombotic microangiopathy. A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 754, doi. 10.1177/10781552211067433

By:

Scheggi, Valentina;
Merilli, Irene;
Cesaroni, Edoardo;
Alterini, Bruno

Publication type:

Article

Myocarditis and diaphragmatic rhabdomyolysis with respiratory failure in a patient with metastatic melanoma treated with Nivolumab.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 750, doi. 10.1177/10781552211067424

By:

Baldessari, Cinzia;
Pugliese, Giuseppe;
Venturelli, Marta;
Greco, Stefano;
Ferrara, Leonardo;
Longo, Giuseppe;
Dominici, Massimo;
Depenni, Roberta

Publication type:

Article

Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 746, doi. 10.1177/10781552211066888

By:

Değerli, Ezgi;
Alkan, Gülin;
Öztaş, Nihan Şentürk;
Bedir, Şahin;
Derin, Sümeyra;
Demirci, Nebi Serkan

Publication type:

Article

Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 740, doi. 10.1177/10781552211066073

By:

Uğraklı, Muzaffer;
Araz, Murat;
Demirkıran, Aykut;
Çelik, Ahmet Faruk;
Karakurt Eryılmaz, Melek;
Karaağaç, Mustafa;
Artaç, Mehmet

Publication type:

Article

Refractory cytokine release reaction to Nivolumab: Following desensitization algorithms to optimize the management of drug hypersensitivity.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 736, doi. 10.1177/10781552211064312

By:

Sánchez Togneri, Laura;
Duran, Ignacio;
Rodríguez Fernández, Fernando;
de las Vecillas, Leticia

Publication type:

Article

Drug-induced hypersensitivity syndrome following temozolimide for glioblastoma multiforme and the role of desensitization therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 733, doi. 10.1177/10781552211062569

By:

Ambur, Austin;
Ambur, Lindsay;
Khan, Leila;
Nathoo, Rajiv

Publication type:

Article

Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 729, doi. 10.1177/10781552211062148

By:

Banerjee, Rahul;
Lo, Mimi;
Klein, Liviu;
Aras, Mandar;
Logan, Aaron C.

Publication type:

Article

Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 725, doi. 10.1177/10781552211060730

By:

Yılmaz, Fatma;
Albayrak, Murat;
Tığlıoğlu, Pınar;
Tığlıoğlu, Mesut;
Sağlam, Buğra;
Reis Aras, Merih;
Maral, Senem;
Afacan Öztürk, Hacer Berna

Publication type:

Article

Diabetic ketoacidosis as a hallmark of autoimmune diabetes occurring after two cycles of cemiplimab.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 722, doi. 10.1177/10781552211060523

By:

Jouneghani, Nasrin Saleh;
Phillip, John;
Dasanu, Constantin A

Publication type:

Article

Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 717, doi. 10.1177/10781552211057867

By:

Hadfield, Matthew J.;
Turshudzhyan, Alla;
Shalaby, Khalid;
Reddy, Aswanth

Publication type:

Article

Case report of sacituzumab govitecan-hziy-induced neutropenia in a patient with metastatic triple-negative breast cancer and a uridine diphosphate glucuronosyltransferase family 1 member A1 poor metabolizer genotype.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 710, doi. 10.1177/10781552211057486

By:

Baek, Grace;
Jung, Lindsey;
Duong, Arianne;
Gralow, Julie

Publication type:

Article

Capecitabine-induced leukoencephalopathy in a patient with triple-negative breast cancer: A case report and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 703, doi. 10.1177/10781552211056856

By:

Liu, Li;
Brown, Erika N;
Abu-Shahin, Fadi I

Publication type:

Article

Life-threatening sustained hypocalcemia following Denosumab use in metastatic prostate cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 698, doi. 10.1177/10781552211055407

By:

Patell, Kanchi;
Ajay, Kumar;
Al Armashi, Abdul Rahman;
Bawwab, Ameed;
Ravakhah, Keyvan

Publication type:

Article

Anticancer drug waste minimization and cost-saving study by using a closed-system transfer device for chemotherapy compounding.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 605, doi. 10.1177/10781552211008527

By:

adade, Casimir adade;
Diop, Boubacar BF;
Attjioui, Houda;
cheikh, Amine;
Mefetah, Hafid;
Bouatia, Mustapha

Publication type:

Article

Hypersensitivity reactions to paclitaxel: The Mexican experience of rapid desensitization.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 598, doi. 10.1177/10781552211008503

By:

González, Rosalaura V Villarreal;
Díaz, Sandra N González;
Cruz, Rodrigo A de la Cruz;
Gutiérrez, Oscar Vidal;
Quezada, Cindy E de Lira

Publication type:

Article

A study to assess the impact of pharmaceutical care services to cancer patients in a tertiary care hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 588, doi. 10.1177/10781552211005003

By:

Karthikeyan, Kavya;
Sunil, Vinayak B;
Alex, Soumya M;
CS, Madhu

Publication type:

Article

Publication rates of hematology/oncology abstracts presented at major pharmacy association meetings.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 582, doi. 10.1177/10781552211004700

By:

Wooten, Kiley M;
Arnall, Justin R;
Bowser, Kiarra M;
J Pennell, Laurie;
Wade-Davis, Jazmin N;
Olin, Jacqueline L;
Taylor, Margaret;
Moore, Donald C

Publication type:

Article

Incidence of hypersensitivity reactions in patients on H1-receptor antagonists receiving oxaliplatin-based chemotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 577, doi. 10.1177/10781552211003958

By:

Barrett, Christine;
Park, Seon Jo;
Edmondson, Lindsay;
Monga, Dulabh

Publication type:

Article

Older adults with colon cancer are not different from younger ones, but treated differently: Retrospective analysis from single centre.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 569, doi. 10.1177/10781552211002912

By:

Oytun, Merve Güner;
Bulut, Gülcan;
Gökmen, Erhan;
Doğu, Burcu B;
Karabulut, Bülent

Publication type:

Article

Oral metronomic chemotherapy is a cost effective alternative to pazopanib in advanced soft tissue sarcoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 3, p. 560, doi. 10.1177/10781552211000113

By:

Sharma, Aparna;
Kataria, Babita;
Biswas, Bivas;
Bakhshi, Sameer;
Pushpam, Deepam

Publication type:

Article